National survey on infiltrative breast cancer - CSI
Study identifier:NIS-OFR-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
National prospective survey on women with a diagnosis of infiltrative breast cancer
Medical condition
infiltrative breast cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Female
Actual Enrollment
1500
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jun 2007
Primary Completion Date: 01 Jul 2008
Study Completion Date: 01 Jul 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | - |
Contacts
Investigators
Principal Investigator
Alain Castaigne
AstraZeneca
